SGMT

Sagiment Biosciences (SGMT)

Sagiment Biosciences Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:SGMT

1 2 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/13	19:07	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:SGMT	Sagiment Biosciences Inc
2024/06/08	05:07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SGMT	Sagiment Biosciences Inc
2024/06/08	05:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SGMT	Sagiment Biosciences Inc
2024/06/06	19:03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SGMT	Sagiment Biosciences Inc
2024/05/23	20:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SGMT	Sagiment Biosciences Inc
2024/05/15	21:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SGMT	Sagiment Biosciences Inc
2024/05/15	20:00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SGMT	Sagiment Biosciences Inc
2024/05/09	05:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SGMT	Sagiment Biosciences Inc
2024/05/09	05:05	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:SGMT	Sagiment Biosciences Inc
2024/05/06	21:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SGMT	Sagiment Biosciences Inc
2024/03/25	20:00	GlobeNewswire Inc.	Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors	NASDAQ:SGMT	Sagiment Biosciences Inc
2024/03/25	19:15	GlobeNewswire Inc.	Sagimet Biosciences Reports Full Year 2023 Financial Results and Provides Corporate Updates	NASDAQ:SGMT	Sagiment Biosciences Inc
2024/02/29	22:00	GlobeNewswire Inc.	Sagimet Biosciences to Participate in Two Upcoming Investor Conferences	NASDAQ:SGMT	Sagiment Biosciences Inc
2024/02/15	08:10	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:SGMT	Sagiment Biosciences Inc
2024/02/15	06:37	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:SGMT	Sagiment Biosciences Inc
2024/02/06	06:34	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:SGMT	Sagiment Biosciences Inc
2024/02/03	06:36	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SGMT	Sagiment Biosciences Inc
2024/02/03	06:05	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:SGMT	Sagiment Biosciences Inc
2024/02/01	06:56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SGMT	Sagiment Biosciences Inc
2024/02/01	06:55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SGMT	Sagiment Biosciences Inc
2024/01/31	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SGMT	Sagiment Biosciences Inc
2024/01/26	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:SGMT	Sagiment Biosciences Inc
2024/01/26	10:58	GlobeNewswire Inc.	Sagimet Biosciences Announces Pricing of Public Offering of Series A Common Stock	NASDAQ:SGMT	Sagiment Biosciences Inc
2024/01/24	20:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SGMT	Sagiment Biosciences Inc
2024/01/24	20:08	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:SGMT	Sagiment Biosciences Inc
2024/01/24	07:45	GlobeNewswire Inc.	Sagimet Biosciences Announces Proposed Public Offering of Series A Common Stock	NASDAQ:SGMT	Sagiment Biosciences Inc
2024/01/24	07:31	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:SGMT	Sagiment Biosciences Inc
2024/01/22	22:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SGMT	Sagiment Biosciences Inc
2024/01/22	21:00	GlobeNewswire Inc.	Sagimet Biosciences Announces Positive Topline Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 NASH	NASDAQ:SGMT	Sagiment Biosciences Inc
2023/12/30	06:16	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SGMT	Sagiment Biosciences Inc